Fundamentals Overview
Incyte Corporation is in the middle of its 52-week range with attractive valuation, trading relatively flat today.
Valuation attractive
Intrinsic value (DCF)
+27% upside vs price
Profitability
Risk (Beta)
0.86 — in line vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +27% upside vs price · Analyst grade: A
Pressures (Sell):
3M vs S&P 500: -9.4%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A. Recent institutional grades: mixed. Current institutional positions: Buy: 8, Equal Weight: 4, Hold: 2, In Line: 1, Neutral: 3, Outperform: 1, Overweight: 8, Sector Perform: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $123.29; current price is $97.10. That’s a +27% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 15.45 |
| DCF value (model) | $123.29 (27% upside) |
| PEG (TTM) | 0 |
| P/B (TTM) | 3.71 |
| P/S (TTM) | 3.76 |
| P/FCF (TTM) | 14.27 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.32 |
| Quick Ratio (TTM) | 3.25 |
| Cash Ratio (TTM) | 2.04 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 25.03% |
| Gross margin (TTM) | 91.8% |
| Operating margin (TTM) | 26.35% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for INCY.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-30 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-25 |
| UBS | maintain | Neutral | Neutral | 2026-03-25 |
| Jefferies | downgrade | Buy | Hold | 2026-03-16 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-09 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-03-05 |
| Barclays | maintain | Overweight | Overweight | 2026-02-18 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-02-11 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-02-11 |
| Stifel | maintain | Buy | Buy | 2026-02-11 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-11 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-06 |
| Barclays | maintain | Overweight | Overweight | 2026-02-04 |
| Wells Fargo | downgrade | Overweight | Equal Weight | 2026-01-20 |
| TD Cowen | maintain | Buy | Buy | 2026-01-13 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-01-06 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-12-08 |
| Mizuho | upgrade | Neutral | Outperform | 2025-12-08 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-08 |
| Barclays | maintain | Overweight | Overweight | 2025-11-24 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-11-04 |
| Guggenheim | upgrade | Neutral | Buy | 2025-11-03 |
| Barclays | maintain | Overweight | Overweight | 2025-10-29 |
| Truist Securities | maintain | Hold | Hold | 2025-10-29 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-10-29 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-10-29 |
| JP Morgan | maintain | Neutral | Neutral | 2025-10-09 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-09-24 |
| Stifel | maintain | Buy | Buy | 2025-09-22 |
| Guggenheim | maintain | Neutral | Neutral | 2025-09-19 |